[ccpw id="5"]

Home.forex news reportKeyBanc Reduces its Price Target on Hinge Health, Inc. (HNGE) to $55...

KeyBanc Reduces its Price Target on Hinge Health, Inc. (HNGE) to $55 and Maintains an Overweight Rating

-


Hinge Health, Inc. (NYSE:HNGE) is among the 11 Newly-Listed NYSE Stocks to Buy Now.

KeyBanc Reduces its Price Target on Hinge Health, Inc. (HNGE) to $55 and Maintains an Overweight Rating
KeyBanc Reduces its Price Target on Hinge Health, Inc. (HNGE) to $55 and Maintains an Overweight Rating

On February 11, 2026, KeyBanc reduced its price target on Hinge Health, Inc. (NYSE:HNGE) to $55 from $70 and maintained an Overweight rating.

That same day, Evercore ISI analyst Elizabeth Anderson lowered the price target to $50 from $65 while keeping an Outperform rating. Elizabeth Anderson said Hinge Health exceeded expectations on Q4 revenue and initiated FY26 guidance above Street estimates. Although the price target was trimmed, Elizabeth Anderson expects a favorable reaction given what the firm characterized as “conservative” 2026 guidance and the stock trading near a $0 terminal value. Also on February 11, 2026, Canaccord cut its price target to $53 from $65 and reiterated a Buy rating. Canaccord said the company delivered a strong 4Q’25 beat versus estimates and guidance, along with a 1Q’26 and full-year outlook that came in better than anticipated. The firm added that Hinge has room to continue expanding and generating strong financial results, with guidance assuming stable pricing and flat yield.

On February 10, 2026, Hinge Health reported Q4 revenue of $170.7M compared with the consensus of $156.8M. Co-Founder and CEO Daniel Perez described an “exceptional quarter,” citing strong win rates and a record number of eligible lives added during the year. Daniel Perez pointed to commercial momentum, expanding margins, and solid cash generation, expressing confidence in the company’s ability to further automate care delivery and drive growth with increased margins in 2026.

Hinge Health, Inc. (NYSE:HNGE) focuses on scaling and automating healthcare delivery through an AI-powered care model, wearable devices, and clinician access to provide evidence-based services for musculoskeletal conditions.

While we acknowledge the potential of HNGE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Most Profitable Undervalued Stocks to Buy and 11 Best Mining Stocks to Buy According to Wall Street.

Disclosure: None.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

LATEST POSTS

High-interest online banking with minimal fees

Summary: Headquartered in San Diego, UFB Direct is an online division of Axos Bank. It offers checking, savings, and money market...

High-yield accounts to help your money grow faster

Summary: TAB Bank is a Utah-based online bank that was founded in 1998 as Transportation Alliance Bank and primarily served customers...

Could the U.S. strike Iran?

Where diplomacy and military posture stand Senior U.S. officials...

Singapore Inflation Rises To 13-month High

Singapore's consumer price inflation accelerated in January to the highest level in just over a year amid higher accommodation costs, data published by...

Follow us

0FansLike
0FollowersFollow
0SubscribersSubscribe

Most Popular

spot_img